Shenzhen Rivaroxaban Co.,Ltd
Home
About us
Products
Rivaroxaban
Pharmaceutical Intermediates
Tegprazan
VeMurafenib
Anti-diabetic
Antiviral Drug
Antidepressants
Anti-cancer Drugs
High Polymer Materials
Complementary Medicines
Cardiovascular Medications
News
Blog
Contact us
Language
English
Français
Deutsch
Español
Italiano
Português
日本語
한국어
Русский
Home
>
Blog
LATEST NEWS
Growing use of weight loss drugs heightens cost concerns for insurers, employers
Study shows costly weight loss drug may also cut risks of heart attacks
Long
Anti
Triglyceride
Jun 14, 2024
Growing use of weight loss drugs heightens cost concerns for insurers, employers
read more
Jun 01, 2024
Study shows costly weight loss drug may also cut risks of heart attacks
read more
May 18, 2024
Long
read more
May 04, 2024
Anti
read more
Apr 21, 2024
Triglyceride
read more
Apr 07, 2024
Produce prescriptions linked to improved health outcomes for people at risk of cardiovascular disease
read more
Mar 25, 2024
Polypills Added to List of WHO’s Essential Medicines
read more
Mar 11, 2024
The Global Clot Busting Drugs Market size is expected to reach $47.7 billion by 2030, rising at a market growth of 7.9% CAGR during the forecast period
read more
Feb 26, 2024
Aspirin can help reduce risk of second heart attack, study finds, but less than half of eligible adults take it
read more
Feb 13, 2024
CMS names 10 drugs up for first price negotiations under IRA
read more
Jan 30, 2024
Traditional medicine can improve people
read more
Jan 16, 2024
Wegovy patients saw 20% reduction in cardiovascular risks, drugmaker says
read more
first
1
2
3
4
5
6
7
last